Halaman 2 - Kemoterapi untuk kanker paru-paru Dokter Terbaik - TOP-39 dokter

Dr. Alemdar berspesialisasi dalam onkologi medis dengan fokus pada pengobatan kanker paru-paru di Kompleks Rumah Sakit Medical Park Antalya.

• Bersertifikat dewan dalam onkologi medis sejak 2018
• Lebih dari 15 tahun pengalaman dalam penyakit dalam dan onkologi
• Terlatih di Universitas Akdeniz – institusi medis terkemuka di Turki
• Bekerja dengan protokol kemoterapi canggih untuk kanker paru-paru

Profesor Felip memimpin uji coba kanker toraks di Rumah Sakit Quiron Barcelona, berspesialisasi dalam optimalisasi kemoterapi dan integrasi imunoterapi untuk kanker paru-paru.

• Anggota aktif Spanish Lung Cancer Group dan ESMO
• Penerima Penghargaan ESMO Women for Oncology Award
• Ketua Bersama Kongres WCLC ke-20 di Barcelona
• Profesor di Universitat de Vic, membimbing rekan onkologi

Prof. Paksoy adalah onkolog medis bersertifikat ESMO dengan fokus kuat pada kanker paru-paru, berpartisipasi dalam uji klinis internasional untuk perawatan lanjutan.

• Menyelesaikan fellowship onkologi medis di Institut Onkologi Universitas Istanbul
• Menerbitkan berbagai studi tentang pengobatan dan hasil kanker paru-paru
• Associate Professor di Departemen Onkologi Medis Universitas Medipol Istanbul
• Berpartisipasi sebagai subinvestigator dalam uji coba Kanker Paru Non-Sel Kecil (NSCLC) ALK-positif Pfizer

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Profesor Madya Onkologi Medis di Rumah Sakit Liv Topkapı Universitas İstinye, dengan keahlian penelitian dan klinis yang luas dalam pengobatan kanker paru-paru.

• Anggota American Society of Clinical Oncology (ASCO) sejak 2018
• Telah menerbitkan berbagai penelitian tentang hasil dan efikasi pengobatan kanker paru-paru
• Berspesialisasi dalam protokol kemoterapi yang dipersonalisasi untuk pasien kanker paru-paru

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Raj Nagarkar telah melakukan 50.000+ operasi kanker, dengan spesialisasi dalam Onkologi Bedah Payudara dan Toraks di HCG Manavata Cancer Centre.

• 19 tahun pengalaman onkologi bedah
• Terlatih di Tata Memorial Hospital dan Royal College of Surgeons
• Terlibat dalam 200+ uji klinis
• Profesor untuk DNB Superspecialty Surgical Oncology
• Fokus pada peningkatan kualitas hidup pasien

Dr. Shaunak mempresentasikan penelitian tentang kanker lambung di Gastrointestinal Cancer Symposium yang elit oleh ASCO. Beliau berspesialisasi dalam terapi target dan dasar molekuler kanker.

• Menyelesaikan DNB dalam Onkologi Medis dari Indraprastha Apollo Hospital
• Residensi Senior dalam Penyakit Dalam di Shyam Shah Medical College
• Registrar dalam Onkologi Medis di Jawaharlal Nehru Cancer Hospital
• Memberikan kuliah di International Winter School of Oncology

Dr. Lalit telah melakukan lebih dari 10.000 operasi besar, dengan fokus pada operasi kanker invasif minimal untuk hasil yang sangat baik.

• Fellowship dalam Onkologi Bedah di Tata Medical Centre, Kolkata
• Berspesialisasi dalam operasi kanker gastrointestinal
• Peneliti utama pendamping dalam berbagai studi penelitian asli
• Asisten Profesor di State Cancer Institute dan Government Cancer Hospital
• Dikenal karena pendekatan yang ramah pasien dan etis

Dr. Shaikh berspesialisasi dalam preservasi organ dan rehabilitasi fungsional untuk pasien kanker mulut, memastikan kualitas hidup.

• 3 tahun pengalaman dalam Onkologi Bedah
• Keahlian dalam bedah maksilofasial mayor dan bedah kepala & leher
• Pelatihan Fellowship dalam Onkologi Bedah Kepala & Leher
• Fokus pada kebersihan mulut preventif dan diagnosis dini
• Peneliti dengan banyak publikasi di bidang ini

Dr. Shruti Kate berspesialisasi dalam pengobatan kanker paru-paru dan mempresentasikan penelitiannya di Konferensi Dunia tentang Kanker Paru-paru di Toronto – penerima tunggal penghargaan perjalanan dari India.

• Dilatih di Tata Memorial Hospital – pusat kanker terkemuka
• Keahlian dalam imunoterapi dan terapi metronomik untuk kanker stadium lanjut
• Anggota ASCO, ESMO, dan IASCLC – perkumpulan onkologi terkemuka
• Menangani semua tumor padat, termasuk kanker paru-paru dan payudara

Menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde membawa keahlian kedokteran nuklir yang luas untuk perawatan kanker paru-paru.

• 12 tahun pengalaman dalam kedokteran nuklir
• Spesialisasi dalam pemindaian PET-CT dan terapi radioiodin
• Makalah yang diterbitkan di berbagai jurnal medis
• Bekerja di HCG Manavata Cancer Centre

Dr. Sridhar P.S. adalah seorang onkolog radiasi dengan pelatihan khusus dalam radioterapi untuk pengobatan kanker paru-paru.

• Pengalaman lebih dari 20 tahun di bidang onkologi radiasi
• Terlatih dalam radioterapi di Banaras Hindu University
• Diplomate of National Board dalam radioterapi
• Anggota dari beberapa komunitas onkologi bergengsi